Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03668067 · ClinicalTrials.gov registry record
Performance of 2WIN Photoscreener With Corneal Reflex Compared to School Bus Retinoscopy by AAPOS Guidelines
A clinical trial, sponsored by Alaska Blind Child Discovery.
- Completed
- Registry status
- 471
- Enrollment target
NCT03668067: Completed study, sponsored by Alaska Blind Child Discovery.
NCT03668067 is a clinical trial that has completed, run by Alaska Blind Child Discovery. The registered enrollment target is 471 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03668067 has completed, sponsored by Alaska Blind Child Discovery.
- COMPLETED
- Registry status
- 471 participants
- Enrollment target
Study Summary
Pediatric eye patients receive infrared photoscreener screening and skiascopy as a part of routine examination to compare ability to detect amblyopia risk factors.
Primary Outcome
Whether pre-defined, age-related risk factor is present. AAPOS has published standard levels of these refractive errors or binocular misalignment that render a child at risk of developing sight-threatening amblyopia.
Interventions
- DEVICE 2WIN photoscreener
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2018-10-31 |
What the finished NCT03668067 record still lists
NCT03668067 is an observational study that tracks outcomes without assigning an intervention. The registered 471 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 2WIN photoscreener is the first listed.
NCT03668067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03668067 about?
NCT03668067 is a clinical study titled "Performance of 2WIN Photoscreener With Corneal Reflex Compared to School Bus Retinoscopy by AAPOS Guidelines". Pediatric eye patients receive infrared photoscreener screening and skiascopy as a part of routine examination to compare ability to detect amblyopia risk factors.
What is the current status of trial NCT03668067?
This trial is currently completed. The enrollment target is 471 participants. The study started on 2018-04-02. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03668067?
The interventions under investigation include: 2WIN photoscreener (DEVICE).
Who is sponsoring clinical trial NCT03668067?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03010150 · 471 participants
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
- NCT05201404 · 471 participants · Phase 3
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
- NCT06947187 · 472 participants · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI